# Tobacco Treatment in the Context of Lung Cancer Screening - Administrative Supplement

> **NIH NIH K07** · MEDICAL UNIVERSITY OF SOUTH CAROLINA · 2020 · $11,512

## Abstract

PROJECT ABSTRACT FROM ORIGINAL SUBMISSION
The activities proposed in this application will assist Dr. Alana Rojewski's development as a clinical researcher
with a focus on tobacco treatment in cancer prevention and control, particularly integrating tobacco treatment
in the oncology and oncology screening setting. The specific career goals of this application are to: (1) Develop
expertise in integrating tobacco treatment in the thoracic oncology and lung cancer screening (LCS) setting; (2)
Develop mastery in clinical trials research; (3) Develop expertise in health services research; and (4) to solidify
skills in research dissemination. These goals will be accomplished through coursework, seminars, journal
clubs, mentored research, manuscript authorship, grant development, and collaboration with other
investigators in the rich research environment at Medical University of South Carolina (MUSC). Hollings
Cancer Center at MUSC recently established a LCS program, for which the candidate's primary mentor serves
as the Co-Director. Screening for lung cancer at earlier, more treatable stages has the potential to reduce
mortality from the U.S.'s most deadly cancer. Annual screening with low-dose computed tomography (LDCT) is
now recommended for high risk individuals based on age and smoking history. The clinical ramifications of
smoking cessation following a LDCT could be profound. To complement the career objectives, the research
plan will evaluate a smoking cessation intervention for LCS patients. The primary aim of the study is to conduct
a 2-arm pilot randomized clinical trial with patients referred for LCS who smoke (N = 80) to evaluate 7-day
point prevalence abstinence rates and determine effect size estimates among participants who receive a
standard intervention (brief counseling session at time of LCS) versus a medication and text messaging
intervention (MTI; standard intervention + 8 weeks of NRT + gain-framed text messages with medication use
reminders). A secondary aim will be to examine 7-day point prevalence abstinence rates and determine effect
size estimates at the 3-month follow-up. Further, as exploratory aims, mediators and moderators of smoking
cessation outcomes (i.e., nicotine dependence, medication adherence, positive lung finding from the scan
[e.g., nodule is present]) and cost-effectiveness of the intervention will be evaluated. The proposed research
has numerous strengths including: a) a timely research question, namely how to optimally enhance smoking
cessation in current smokers who are receiving LCS; b) gain-framed smoking cessation text messaging
specifically developed for LCS patients; and c) potential to easily translate the findings to the growing number
of LCS programs across the country. Research on tobacco treatment interventions for LCS patients could
reduce the future incidence of cancer and mortality for this high-risk patient population. The research plan will
serve as a complement to the candidate's career develo...

## Key facts

- **NIH application ID:** 10128086
- **Project number:** 3K07CA214839-03S1
- **Recipient organization:** MEDICAL UNIVERSITY OF SOUTH CAROLINA
- **Principal Investigator:** Alana Rojewski
- **Activity code:** K07 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $11,512
- **Award type:** 3
- **Project period:** 2020-04-01 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10128086

## Citation

> US National Institutes of Health, RePORTER application 10128086, Tobacco Treatment in the Context of Lung Cancer Screening - Administrative Supplement (3K07CA214839-03S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10128086. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*